FundingWatcher
Home / Startups / Top biotech startups / Biotech startups that raised Series B / Biotech startups that raised Series B in Hangzhou, China

Biotech startups that raised Series B in Hangzhou, China

Updated 16 Nov 2026

Reset
Biotech startups that raised Series B in Hangzhou, China
One-time CSV
  • 23 funded companies, 15 with a website
  • Last round, amount, date, total raised and investors
  • CRM-ready CSV, 18 columns
  • Download right after payment
With founder contacts
Compiled to order
  • The full startup CSV, plus founders and executives
  • Up to 2 founders or CEOs per company, compiled to order
  • Name, job title and LinkedIn URL where found
  • Verified direct email per person
  • Startup CSV at once, contacts CSV by mail within 24 hours
Download right after paymentFree 10-row sampleSecure checkout by Stripe

Not sure about the data?

Download a free 10-row sample first. No account, no payment.

startups-biotech--series-b~hangzhou-zhejiang.csv23 rows × 18 columns
CompanyCityLast roundAmountDate
Qihan BiotechHangzhouSeries B$16.0M2023-09-15
Aorui BioHangzhouSeries B$13.7M2023-09-11

2 rows of the CSV in 5 of its 18 columns.

23
Startups
$316.2M
Total raised
2
Funded in the last 12 months
$43.7M
Raised in the last 12 months

Source: FundingWatcher. Data as of 16 November 2026. "Last 12 months" is the 365 days to that date.

Newest rounds

1 of 23
Company What they do Sector Last round Amount Date Total raised Investors Employees Founded
Qihan Biotech Qihan Biotech develops gene-editing technology for organ transplantation. Biotech Series B $16.0M 2023-09-15 $116.3M Matrix Partners China, Northern Light Venture Capital, CMB International Capital Corporation +1 101 to 250 2017

Table 1. Biotech startups that raised Series B in Hangzhou, China: the 1 newest rounds whose row carries a description, a city, a named fund and an amount. Source: FundingWatcher. Data as of 16 November 2026. Base: 23.

Most active investors

By companies backed
#InvestorTypeLocation CompaniesShare Funded, 12 monthsLatest
1 Hongda Capital Venture capital firm Shanghai, China 1 4%
2 Lucky Source Funds Private equity firm Shenzhen, China 1 4%
3 LYFE Capital Venture capital firm Singapore 1 4%
4 Source Code Capital Venture capital firm Chaoyang, China 1 4%
5 Prox Ventures Venture capital firm Shanghai, China 1 4%
6 Huagai Capital Private equity firm Beijing, China 1 4%
7 ZSCO Private equity firm Hangzhou, China 1 4%
8 Capitech Venture capital firm Xian Shi, China 1 4%
9 Zhengxin Capital Private equity firm Haidian, China 1 4%
10 Shenzhen Capital Group Venture capital firm Nanshan, China 1 4%
11 Yinxinggu Capital Venture capital firm Hangzhou, China 1 4%
12 Delta Capital Venture capital firm Shanghai, China 1 4%
13 SooChow Securities Investment bank Suzhou, China 1 4%
14 Sinowisdom Venture capital firm Hangzhou, China 1 4%
15 Matrix Partners China Venture capital firm Beijing, China 1 4%

Table 2. Biotech startups that raised Series B in Hangzhou, China: the funds recorded as investors in the most companies. Latest: companies they back that raised in the last 12 months. Source: FundingWatcher. Data as of 16 November 2026.

Sectors

SectorsCompaniesShareTotal raised
Health care 18 78% $316.2M
Artificial intelligence 1 4%
Hardware 1 4%

Table 3. Biotech startups that raised Series B in Hangzhou, China by sector. Source: FundingWatcher. Data as of 16 November 2026.

Funding stage

Funding stageCompaniesShareMedian last round
Series B 23 100% $16.0M

Table 4. Biotech startups that raised Series B in Hangzhou, China by stage of the most recent round. Source: FundingWatcher. Data as of 16 November 2026.

Rounds by month

Rounds by monthCompaniesShareRaised
September 2026 1 50% $14.9M
February 2026 1 50% $28.8M

Table 5. Biotech startups that raised Series B in Hangzhou, China: most recent round by month, last 12 months. Source: FundingWatcher. Data as of 16 November 2026.

Most recent round by year

Most recent round by yearCompaniesShareRaised
2026 2 9% $43.7M
2025 3 13% $42.1M
2024 1 4%
2023 8 35% $44.5M
2022 3 13% $14.3M
2021 3 13% $201.0M

Table 6. Biotech startups that raised Series B in Hangzhou, China by year of the most recent round. Source: FundingWatcher. Data as of 16 November 2026.

Founding year

Founding yearCompaniesShare
2020 to 2022 5 22%
2015 to 2019 10 43%
2010 to 2014 6 26%
Before 2010 2 9%

Table 7. Biotech startups that raised Series B in Hangzhou, China by founding year. Source: FundingWatcher. Data as of 16 November 2026.

Team size

Team sizeCompaniesShare
1 to 10 3 15%
11 to 50 10 50%
51 to 100 2 10%
101 to 250 4 20%
501 to 1,000 1 5%

Table 8. Biotech startups that raised Series B in Hangzhou, China by headcount. Source: FundingWatcher. Data as of 16 November 2026.

Method

Sources, fields and exclusions of both files: Method.

Questions

How many biotech startups in Hangzhou, China whose last round is Series B are on the list?
23, in the file dated 16 November 2026. 2 of them closed their most recent round in the last 12 months.
What does the CSV contain?
One row per company, 18 columns: name, domain, website, linkedin, description, founded, employees, city, region, country, sectors, funding_stage, last_round, last_round_date, last_round_usd, total_raised_usd, rounds, investors.
How much does the list cost?
$29 one-time for all 23 rows, no account. Every investor and every startup, two files, cost $99. With founder contacts, up to 2 founders or CEOs per company compiled to order and mailed within 24 hours, $199.
What arrives after payment?
At once: the CSV download link, on the page after payment and by mail.
Can I see rows before buying?
The 2 rows under the buy button are rows of the CSV with every column. The form below it mails 10 rows.
How current is the data?
The file is dated 16 November 2026. The download link serves the current file each time it is opened.

Biotech startups that raised Series B in Hangzhou, China: 23 rows, CSV, $29 one-time.

At once: the CSV download link, on the page after payment and by mail.

Columns: name, domain, website, linkedin, description, founded, employees, city, region, country, sectors, funding_stage, last_round, last_round_date, last_round_usd, total_raised_usd, rounds, investors.

With founder contacts: $199 one-time. List CSV right after payment; up to 2 verified founder or CEO emails per company compiled to order within 24 hours.

Not sure about the data?

Download a free 10-row sample first. No account, no payment.

Biotech at other stages in Hangzhou

Other sectors that raised Series B in Hangzhou

Cite: FundingWatcher, 23 biotech companies in Hangzhou, China whose most recent round is Series B, 16 November 2026. https://fundingwatcher.com/startups/biotech/series-b/hangzhou-zhejiang/